RS

Ravi Shankar Unnikrishnan Nair

Active Director Director DIN 11378601
DIN 11378601 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Shankar Unnikrishnan Nair

Data last updated:

Ravi Shankar Unnikrishnan Nair is a Director at Orantium Life Sciences Private Limited (since 2025). The company operates in Pharma.

DIN 11378601
Primary Designation Director
Industry Pharma
First Appointment 12 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Nov 20252025Active

Board colleagues of Ravi Shankar Unnikrishnan Nair

NameDINCompanyDesignation
Sachin Sukhdeo Nakade11378600Orantium Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Orantium Life Sciences Private Limited
Premium access

Shareholding and investment profile for Ravi Shankar Unnikrishnan Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shankar Unnikrishnan Nair

Ravi Shankar Unnikrishnan Nair currently holds 1 directorship: Orantium Life Sciences Private Limited (Director, since 12 Nov 2025).

Ravi Shankar Unnikrishnan Nair was first appointed on 12 Nov 2025 as Director at Orantium Life Sciences Private Limited.

The current boards of Ravi Shankar Unnikrishnan Nair's companies include Sachin Sukhdeo Nakade (Orantium Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available